Discovered galectin-3 ligand as a serum biomarker of colon cancer
Discovered galectin-3 ligand as a serum biomarker of colon cancer with sensitivity 72% and specificity 80% based on blinded validation in standard reference set.
Skip to content. | Skip to navigation
 |
Early Detection Research NetworkBiomarkers: the key to early detection |
Discovered galectin-3 ligand as a serum biomarker of colon cancerDiscovered galectin-3 ligand as a serum biomarker of colon cancer with sensitivity 72% and specificity 80% based on blinded validation in standard reference set. |
|
A Service of the National Cancer Institute
